Faecal immunochemical testing (FIT) in patients with signs or symptoms of suspected colorectal cancer (CRC): a joint guideline from the Association of Coloproctology …

KJ Monahan, MM Davies, M Abulafi, A Banerjea… - Gut, 2022 - gut.bmj.com
Faecal immunochemical testing (FIT) has a high sensitivity for the detection of colorectal
cancer (CRC). In a symptomatic population FIT may identify those patients who require …

[HTML][HTML] Molecular genetics of early-onset colorectal cancer

O Marx, M Mankarious, G Yochum - World Journal of Biological …, 2023 - ncbi.nlm.nih.gov
Early-onset colorectal cancer (EOCRC) has been rising in global prevalence and incidence
over the past several decades. Environmental influences, including generational lifestyle …

[HTML][HTML] Delphi initiative for early-onset colorectal cancer (DIRECt) international management guidelines

GM Cavestro, A Mannucci, F Balaguer… - Clinical …, 2023 - Elsevier
Background & Aims Patients with early-onset colorectal cancer (eoCRC) are managed
according to guidelines that are not age-specific. A multidisciplinary international group …

Performance of the Fecal Immunochemical Test in Detecting Advanced Colorectal Neoplasms and Colorectal Cancers in People Aged 40–49 Years: A Systematic …

JH Yeh, CH Tseng, WL Wang, CI Chen, YP Liu, YC Lee… - Cancers, 2023 - mdpi.com
Simple Summary Recently, the cases of colorectal cancers has been rising in younger age
(< 50) individuals. Although current guidelines recommend colorectal cancer screening …

A service evaluation of the use of faecal immunochemical tests in symptomatic patients aged under 50 years presenting to primary care

RE Tibbs, SC Benton - Annals of Clinical Biochemistry, 2024 - journals.sagepub.com
Background Most colorectal cancers (CRCs) occur in individuals aged over 50 years;
however, the incidence in younger age groups is increasing. Diagnosis in younger patients …

The role of biomarkers to increase the detection of early-onset colorectal cancer

O Waddell, FA Frizelle, JI Keenan - Medical Research Archives, 2023 - esmed.org
Colorectal cancer is the third most diagnosed cancer worldwide with an estimated 1.93
million cases diagnosed in 2020. Over the past few decades there has been a dramatic rise …

Strategies to Curb the Increasing Burden of Early Onset Colorectal Cancer

T Yen, TR Levin, SG Patel - Techniques and Innovations in Gastrointestinal …, 2023 - Elsevier
The incidence of early onset colorectal cancer (EoCRC), defined as colorectal cancer (CRC)
in patients under age 50, has been increasing in the United States. This is due to a birth …

The use of the faecal immunochemical test during the COVID‐19 pandemic to triage urgent colorectal cancer referrals

F Kamel, S Zulfiqar, WI Penfold, S Weatherell… - Colorectal …, 2022 - Wiley Online Library
Aim During the first wave of the COVID‐19 pandemic in 2020, elective gastrointestinal
endoscopy services were abbreviated for fear of viral transmission. However, urgent …

[PDF][PDF] Clinical practice guidelines

US USMSTF, US USPSTF… - Clinical …, 2023 - researchportal.helsinki.fi
BACKGROUND & AIMS: Patients with early-onset colorectal cancer (eoCRC) are managed
according to guidelines that are not age-specific. A multidisciplinary international group …

Is the quantitative faecal immunochemical test (qFIT) ready for prime time in the US?

DS Keller - Colorectal Disease, 2022 - search.ebscohost.com
Modelling found using qFIT routinely and colonoscopy only if positive qFIT screening results
would translate to a direct cost savings of $1,388 per patient (when each colonoscopy is …